Clinically compatible advances in blood-derived endothelial progenitor cell isolation and reprogramming for translational applications
Sarah Eminli(ReproCELL (United Kingdom)), Amer A. Rana(Maine Medical Center), Jung-Il Moon(ReproCELL (United States)), Kevin Yi(ReproCELL (United States)), Brad Hamilton(ReproCELL (United States)), Baraa Kwieder(University of Cambridge), Fedir N. Kiskin(University of Cambridge), Chris Huang(University of Cambridge), C‐Hong Chang(Yale University), Nicholas W. Morrell(University of Cambridge)
Cited by 6
Related Papers
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension
|Nature Medicine|2015|503
Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension
|Circulation|2001|487
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
|Human Mutation|2006|404
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
|Nature Communications|2018|395